180 participants
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-27
- Start Date:
- 2024-11-21
- Completion:
- 2028-08-31
Conditions
- Advanced Malignancies With Homologous Recombination Deficiency (HRD) (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Metastases)
Interventions
- DRUG
No Results Yet